Renaissance Technologies
BLTE

Renaissance Technologies’s Belite Bio BLTE Stock Holding History

Renaissance Technologies’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.29M Buy
+52,000
New +$8.74M 0.01% 1069
2025
Q4 		– Sell
-2,812
Closed -$208K – 3261
2025
Q3 		$208K Sell
2,812
-1,488
-35% -$97.7K ﹤0.01% 3125
2025
Q2 		$248K Buy
+4,300
New +$262K ﹤0.01% 3099
2024
Q1 		– Sell
-4,900
Closed -$224K – 3712
2023
Q4 		$224K Buy
+4,900
New +$188K ﹤0.01% 3093

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's BLTE Position: Q1 2026 in Review

Renaissance Technologies opened a new position in Belite Bio (BLTE) in Q1 2026: 52,000 shares worth $8.29M. The stake represents 0.01% of the portfolio and ranks #1069 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in BLTE as recently as Q3 2025.

Renaissance Technologies first reported a position in BLTE in Q4 2023 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Renaissance Technologies held 52,000 shares of Belite Bio worth $8.29M as of Q1 2026.
  • Belite Bio was a new Renaissance Technologies position in Q1 2026.
  • Belite Bio made up 0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1069 holding.
  • Renaissance Technologies first reported a position in Belite Bio in Q4 2023 and has held it in 4 quarters since.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.